Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
about
Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts.Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.Contemporary update on neoadjuvant therapy for bladder cancer.
P2860
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Neoadjuvant dasatinib for musc ...... analysis of biologic activity.
@en
Neoadjuvant dasatinib for musc ...... analysis of biologic activity.
@nl
type
label
Neoadjuvant dasatinib for musc ...... analysis of biologic activity.
@en
Neoadjuvant dasatinib for musc ...... analysis of biologic activity.
@nl
prefLabel
Neoadjuvant dasatinib for musc ...... analysis of biologic activity.
@en
Neoadjuvant dasatinib for musc ...... analysis of biologic activity.
@nl
P2093
P1433
P1476
Neoadjuvant dasatinib for musc ...... analysis of biologic activity.
@en
P2093
Ajjai S Alva
Beatrice S Knudsen
Christopher L Corless
Christopher Ryan
Edwin M Posadas
Fangjin Huang
Gary E Gallick
Guru Sonpavde
Jayati Mallick
Liang Cheng
P304
P356
10.1016/J.UROLONC.2015.08.005
P577
2015-09-08T00:00:00Z